10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Total Payout Ratio : -213.02 (As of May. 17, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

10X Capital Venture Acquisition III's current Total Payout Ratio is -213.02.

10X Capital Venture Acquisition III Total Payout Ratio Historical Data

The historical data trend for 10X Capital Venture Acquisition III's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10X Capital Venture Acquisition III Total Payout Ratio Chart

10X Capital Venture Acquisition III Annual Data

Trend

Dec21

Dec22

Total Payout Ratio

-446.32

10X Capital Venture Acquisition III Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Payout Ratio	Get a 7-Day Free Trial						-	-	96.11	-	-

Competitive Comparison of 10X Capital Venture Acquisition III's Total Payout Ratio

For the Shell Companies subindustry, 10X Capital Venture Acquisition III's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10X Capital Venture Acquisition III's Total Payout Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, 10X Capital Venture Acquisition III's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where 10X Capital Venture Acquisition III's Total Payout Ratio falls into.

10X Capital Venture Acquisition III Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

10X Capital Venture Acquisition III's Total Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	311.53	+	0)	/	0.698
	=	-446.32

10X Capital Venture Acquisition III's Total Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-2.291
	=	0.00

10X Capital Venture Acquisition III Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of 10X Capital Venture Acquisition III's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXBU) » Definitions » Total Payout Ratio

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

VCXB:USA

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023